Cullinan Therapeutics, Inc. ($CGEM)
Filing Information
| Accession Number | 0001193125-26-352523 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
90,000
Total Value
$736,800.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Aug 13, 2026 | Exercise/Conversion | 30,000 | $4.30 | $129,000.00 | 192,844 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Aug 13, 2026 | Sale | 30,000 | $20.26 | $607,800.00 | 162,844 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (Right to Buy) | Derivative | Aug 13, 2026 | Exercise/Conversion | 30,000 | $0.00 | $0.00 | 82,987 | Direct | โ | View Details |